LAUREN BAILEY: Open Payments
NPI 1508160805 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 17 payments from 11 companies in 2025. Trend: 2023 $599 · 2024 $508 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $75 |
| Amgen Inc. | 2 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Sage Therapeutics, LLC | 2 | $39 |
| CooperSurgical, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Hologic Sales and Service, LLC | 1 | $16 |
Products named: Veozah, EVENITY, Mirena, ZURZUVAE, Paragard T 380A, MYFEMBREE, SLYND, Qelbree.
Industry payments across DE — which companies pay providers there.
